Alert: Canvas Outage Update

Learn More

Irinotecan Tip Sheet

The following information is intended for use by providers who are attempting to prescribe irinotecan to patients with certain UGT1A1 genetic variants.  

 

For immediate questions, send a secure chat message to Groups: "Pharmacogenomics Service" in UCHealth's EHR.

Patient Education Resources

Clinicians using the UCHealth EHR can use dotphrase: .pgxirinotecantopatient 
UpdateIRI-TS

References:  

  1. Hulshof EC et al. Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan, Eur J Hum Genet. 2022 Nov 28 online ahead of print. PMID: 36443464.
  2. Irinotecan Onivyde prescribing information. https://www.ipsen.com/websites/Ipsen_Online/wp-content/uploads/sites/9/2019/01/21083350/ONIVYDE_USPI.pdf
  3. Díaz-Villamarín X, Nieto-Sánchez MT, Martínez-Pérez M, Novo-González P, Fernández-Varón E, Torres-García A, González Astorga B, Blancas I, Cabeza-Barrera J, Morón R. Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review. Pharmaceutics. 2025 Apr 22;17(5):542. PMID: 40430836.

Webpage updated as of: 4.1.26
editing pen Request an edit to this webpage here.
CCPM logo
CMS Login